CGEN Compugen Ltd

Price (delayed)

$2.24

Market cap

$211.81M

P/E Ratio

6.05

Dividend/share

N/A

EPS

$0.37

Enterprise value

$122.99M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 99

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of ...

Highlights
CGEN's revenue has surged by 163% year-on-year
Compugen's gross margin has increased by 25% YoY
Compugen's equity has surged by 67% YoY but it has decreased by 7% QoQ
Compugen's quick ratio has increased by 22% YoY but it has decreased by 5% QoQ
The debt has grown by 6% YoY
Compugen's EPS has decreased by 2.6% QoQ

Key stats

What are the main financial stats of CGEN

CGEN stock price

How has the Compugen stock price performed over time
Intraday
2.28%
1 week
-19.42%
1 month
-15.15%
1 year
30.99%
YTD
46.41%
QTD
5.16%

Financial performance

How have Compugen's revenue and profit performed over time
Revenue
$72.66M
Gross profit
$63.98M
Operating income
$30.7M
Net income
$34.86M
Gross margin
88.1%
Net margin
48%
The net margin has soared by 194% YoY
Compugen's operating margin has soared by 179% YoY
CGEN's revenue has surged by 163% year-on-year
Compugen's gross margin has increased by 25% YoY

Price vs fundamentals

How does CGEN's price correlate with its fundamentals

Growth

What is Compugen's growth rate over time

Valuation

What is Compugen stock price valuation
P/E
6.05
P/B
2.22
P/S
2.92
EV/EBIT
3.53
EV/EBITDA
N/A
EV/Sales
1.69
Compugen's EPS has decreased by 2.6% QoQ
Compugen's equity has surged by 67% YoY but it has decreased by 7% QoQ
The stock's price to book (P/B) is 13% less than its 5-year quarterly average of 2.5 and 13% less than its last 4 quarters average of 2.5
CGEN's revenue has surged by 163% year-on-year
CGEN's P/S is 92% below its 5-year quarterly average of 33.9 and 64% below its last 4 quarters average of 8.0

Efficiency

How efficient is Compugen business performance
Compugen's ROE has decreased by 14% from the previous quarter
CGEN's ROIC is down by 12% QoQ
CGEN's return on assets is down by 7% since the previous quarter

Dividends

What is CGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CGEN.

Financial health

How did Compugen financials performed over time
CGEN's total assets is 189% greater than its total liabilities
CGEN's total assets is up by 26% year-on-year but it is down by 7% since the previous quarter
The current ratio has grown by 22% YoY but it has contracted by 5% from the previous quarter
The debt is 97% less than the equity
Compugen's equity has surged by 67% YoY but it has decreased by 7% QoQ
The debt to equity is down by 40% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.